Shree Ram Proteins Approves Sale of Entire Undertaking for Approximately 17 Crore
Shree Ram Proteins Limited announced a significant board approval regarding the potential divestment of its core business. The company's Board of Directors, at a meeting held on August 10, 2026, approved the proposal for the sale or transfer of the whole or substantially the whole undertaking of the Company.The transaction is valued at an aggregate consideration of approximately 17.00 Crore, pending shareholder approval and the receipt of applicable statutory and regulatory clearances.
As part of the strategic move, the Board also reviewed and approved the necessary Postal Ballot Notice, along with a calendar of events, designed to seek formal approval from shareholders regarding this material transaction.
In support of the process, the Directors appointed Ms. Payal Dhamecha, Proprietor of M/s. Payal Dhamecha & Associates (a Practicing Company Secretary), as the Scrutinizer. This appointment is intended to conduct the Postal Ballot process through remote e-voting in a transparent manner.
Key details regarding the board’s decisions are summarized below:
| Matter | Board Action Status | Consideration / Details |
|---|---|---|
| Sale of Undertaking | Approved (Subject to Shareholder and Statutory Approval) | Approximately 17.00 Crore |
| Shareholder Voting | Postal Ballot Notice & Calendar approved | For seeking approval of the sale |
| Process Management | Scrutinizer Appointed | Ms. Payal Dhamecha |
SRPL Stock Price Movement
Today, shares of Shree Ram Proteins Limited edged higher, settling at ₹0.34 after climbing 3.03% in post-market trading. The stock traded 239,095 shares that day, showing volatility between a low of ₹0.32 and the closing price.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.